MX2010004353A - Combinación anticonceptiva oral entiemética. - Google Patents

Combinación anticonceptiva oral entiemética.

Info

Publication number
MX2010004353A
MX2010004353A MX2010004353A MX2010004353A MX2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A MX 2010004353 A MX2010004353 A MX 2010004353A
Authority
MX
Mexico
Prior art keywords
antiemetic
oral contraceptive
contraceptive combination
combination
contraceptive formulation
Prior art date
Application number
MX2010004353A
Other languages
English (en)
Inventor
Sheetal Kulkarni
Srirupa Das
Harshal Anil Jahagirdar
Satish Dalal
Shirish Kulkarni
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Publication of MX2010004353A publication Critical patent/MX2010004353A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con un método para reducir la incidencia de náuseas y vómito asociados con la administración de una formulación anticonceptiva oral que contienen progestina y/o estrógeno y un antiemético. La formulación anticonceptiva oral preferida está constituida por levonorgestrel y un antiemético.
MX2010004353A 2007-10-25 2008-10-24 Combinación anticonceptiva oral entiemética. MX2010004353A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1460KO2007 2007-10-25
PCT/IN2008/000704 WO2009054007A1 (en) 2007-10-25 2008-10-24 Antiemetic-oral contraceptive combination

Publications (1)

Publication Number Publication Date
MX2010004353A true MX2010004353A (es) 2010-07-06

Family

ID=40343574

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010004353A MX2010004353A (es) 2007-10-25 2008-10-24 Combinación anticonceptiva oral entiemética.

Country Status (8)

Country Link
US (1) US8507465B2 (es)
EP (1) EP2211866A1 (es)
JP (1) JP2011500793A (es)
AU (1) AU2008315319A1 (es)
BR (1) BRPI0818852A2 (es)
MX (1) MX2010004353A (es)
WO (1) WO2009054007A1 (es)
ZA (1) ZA201003697B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010007629A1 (en) * 2008-07-15 2010-01-21 Lupin Limited A kit comprising anti-emetic and oral contraceptive
DE102011051308A1 (de) * 2011-06-24 2012-12-27 Hennig Arzneimittel Gmbh & Co. Kg Herstellungsverfahren und Arzneiform
US9301920B2 (en) 2012-06-18 2016-04-05 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
BR112014012444B1 (pt) 2011-11-23 2021-12-14 Therapeuticsmd, Inc Composição farmacêutica compreendendo estradiol solubilizado, progesterona e um agente de solubilização, bem como usos desta para tratar um sintoma relacionado à menopausa em uma mulher
US20150196640A1 (en) 2012-06-18 2015-07-16 Therapeuticsmd, Inc. Progesterone formulations having a desirable pk profile
US10806697B2 (en) 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en) 2012-06-18 2013-12-19 Therapeuticsmd, Inc. Transdermal hormone replacement therapies
US10806740B2 (en) 2012-06-18 2020-10-20 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10568891B2 (en) 2012-12-21 2020-02-25 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en) 2012-12-21 2020-01-21 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en) 2012-12-21 2015-11-10 Therapeuticsmd, Inc. Soluble estradiol capsule for vaginal insertion
US11266661B2 (en) 2012-12-21 2022-03-08 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US10471072B2 (en) 2012-12-21 2019-11-12 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
US11246875B2 (en) 2012-12-21 2022-02-15 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
AU2015264003A1 (en) 2014-05-22 2016-11-17 Therapeuticsmd, Inc. Natural combination hormone replacement formulations and therapies
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
BR112018070199A2 (pt) 2016-04-01 2019-01-29 Therapeuticsmd Inc composição farmacêutica de hormônio esteroide
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2558297A (en) * 1996-05-16 1997-12-05 Gynetics Inc. Emergency contraceptive kit
CA2354250A1 (en) 2001-07-27 2003-01-27 Mario Hannouche Use of h1 histamine receptor antagonists for the prevention or attenuation of side effects associated with high doses of female hormones
CN1485093A (zh) 2003-08-22 2004-03-31 广州贝氏药业有限公司 复方避孕药灭吐灵制剂

Also Published As

Publication number Publication date
AU2008315319A1 (en) 2009-04-30
WO2009054007A1 (en) 2009-04-30
EP2211866A1 (en) 2010-08-04
US8507465B2 (en) 2013-08-13
BRPI0818852A2 (pt) 2015-04-14
US20100240626A1 (en) 2010-09-23
ZA201003697B (en) 2011-03-30
JP2011500793A (ja) 2011-01-06

Similar Documents

Publication Publication Date Title
MX2010004353A (es) Combinación anticonceptiva oral entiemética.
EA200900491A1 (ru) Применение эстрадиола валерата или 17в-эстрадиола в комбинации с диеногестом для перорального лечения для поддержания и/или повышения полового влечения у особи женского пола
TN2011000656A1 (en) Pharmaceutical composition for emergency contraception
TW200605882A (en) Progesterone receptor modulators comprising pyrrole-oxindole derivatives and uses thereof
NZ615430A (en) Method for on-demand contraception
MY169516A (en) Pharmaceutical composition containing a tetrahydrofolic acid
TW200605880A (en) Progesterone receptor antagonist contraceptive regimens and kits
AU2012293593A8 (en) Use of estetrol as emergency contraceptive
TW200603813A (en) Cyclic progestin regimens and kits
WO2006127618A3 (en) Compressible gum based delivery systems for the release of ingredients
HUP0400646A2 (hu) Szteroid hormonkészítmények és előállításukra szolgáló eljárások
WO2008031631A3 (en) Oral modified release formulations
NZ602698A (en) Parenteral pharmaceutical form which releases aromatase inhibitor and gestagens, for the treatment of endometriosis
MX2007000273A (es) Composiciones de liberacion sostenida que contiene moduladores del receptor de progesterona.
DE602007007991D1 (de) Kleinvolumige, orale, transmukosale dosierungsformen mit sufentanil zur schmerzbehandlung
CR11493A (es) Sistema de administracion vaginal
WO2007098128A3 (en) Phenylephrine-containing liquid formulations
MX2009005724A (es) Comprimidos bicapa de estrogenos/serm y estrogenos/progestina.
EP1637167A3 (en) New injectable formulations containing progesterone
WO2008113901A3 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
AU2010293105A8 (en) Oral suspension formulations of esclicarbazepine acetate
MX2010005198A (es) Composiciones liquidas que comprenden valsartan.
MX2009010320A (es) Regimen anticonceptivo oral.
WO2011126810A3 (en) Intravaginal drug delivery device
MA33022B1 (fr) Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil

Legal Events

Date Code Title Description
FG Grant or registration